Elisa Mansfield, Vice President of FSP at Phastar, contributed an article to Pharmaceutical Outsourcing discussing the critical role of selecting the right FSP solution for biotech and biopharma organizations. She explored how these strategic partnerships can optimize quality, financial efficiency, and operational effectiveness.
“By building good-standard partnerships, biotech, and biopharma companies can ensure they maximize quality, efficiency, and operational effectiveness. The importance of these strategic partnerships is only set to increase as new technologies require new levels of expertise and the clinical trials industry evolves to meet the challenges of digital health and increasing data sources.”